Production and functional characterization of two mouse/human chimeric antibodies with specificity for the tumor-associated Tn-antigen

Hybridoma

Volumn 19, Issue 3, 2000, Pages 229-239

  Oppezzo, P ^a   Osinaga, E ^a   Tello, D ^c   Bay, S ^c   Cantacuzene, D ^c   Irigoin, F ^b   Ferreira, A ^b   Roseto, A ^d   Cayota, A ^a   Alzari, P ^c   Pritsch, O ^a  

^a DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^b UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC ANTIBODY; DNA FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 83 D 4; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; COMPLEMENT ACTIVATION; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOGENICITY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELL FUSION; GENETIC VECTORS; HUMANS; HYBRIDOMAS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN M; MICE; MICE, INBRED C57BL; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; MAMMALIA; MINK CELL FOCUS-FORMING VIRUS; MURINAE; OVIS;

EID: 0033855076     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/02724570050109620     Document Type: Article

References (50)

1. An overview of monoclonal antibody therapy of cancer Semin Oncol
2. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy
3. Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E- and P-selectin
4. Chimeric biospecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (MOv18) and displays decreased immunogenicity in patients
5. Immunoglobulin gene expression in transformed lymphoid cells
6. Chimeric human antibody molecules: Mouse antigen-binding-domains with human constant region domains
7. Transfectomas provide novel chimeric antibodies
8. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens
9. Production of a monoclonal antibody as immunohistochemical marker on paraffin embedded tissues using a new immunization method
10. Monoclonal antibody 83D4 immunoreactivity in human tissues: Cellular distribution, and microcytophotometric analysis of immunoprecipitates on tissue sections
11. Immunocytological analysis of the Tn-associated antigen (83D4) in serous effusions from patients with cancer: Comparison with Tn-soluble glycoprotein
12. Detection of a soluble antigen defined by monoclonal antibody 83D4 in serous effusions associated with breast carcinoma
13. Development of an immuno-lectin-enzimatic assay for the detection of serum carcinoma-associated glycoproteins beating Tn determinant
14. Purification and characterization of a breast-cancer-associated glycoprotein not expressed in normal breast and identified by mono-clonal antibody 83D4
15. Analysis of the carcinoma associated epitope defined by monoclonal antibody 83D4
16. T and Tn, general carcinoma antigens
17. Molecular cloning of a monoclonal anti-tumor antibody specific for the Tn antigen and expression of an active single-chain Fv fragment
18. Recombinant antibody constructs in cancer therapy
19. Effects of genetic engineering on the pharmacokinetics of antibodies
20. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines
21. A human cell line from a pleural effusion derived from a breast cancer
22. Purification and characterization of bovine and ovine submaxillary mucins
23. Color test for detection of free terminal amino groups in the solid- phase synthesis of peptides
24. Molecular analysis of four different serum mig with anti-tubulin binding activity in a lymphoma patient: Isotype switch modulates antigen binding affinity (submitted)
25. A murine model of human cold agglutinin disease
26. DNA sequencing with chain-terminating inhibitors
27. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
28. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedures and some applications
29. Study of the in vitro activation of the complement alternative pathway by Echinococcus granulosus hydatid cyst fluid
30. Biospecific interaction analysis using biosensor technology
31. Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology
32. Biochemical basis of tumor-associated carbohydrate antigens. Current trends, future perspectives, and clinical applications
33. T and Tn pancarcinoma markers: Auto-antigenic adhesion molecules in pathogenesis, pre-biopsy carcinoma detection and long-term breast-carcinoma immunotherapy
34. Carcinoma autoantigen T and Tn and their cleavage products interact with Gal/GalNAc-specific receptors on rat Kupffer cells and hepatocytes
35. T-cell recognition of Tn-glycosylated peptide antigens
36. A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy
37. Humanized anti-Lewis Y antibodies: In vitro properties and pharmacokinetics in Rhesus monkeys
38. Signaling antibodies in cancer therapy
39. Use of rituximab, the new FDA-approved antibody
40. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p 185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment
41. Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody
42. A new era for radiolabeled antibodies in cancer?
43. Chimerization of Mu-9. A colon-specific antibody reactive with gastrointestinal carcinomas
44. Epitopic structure of Tn glycophorin A for an anti-Tn antibody (MLS 128)
45. Specificities of anti-sialyl-Tn and anti-Tn monoclonal antibodies generated using novel clustered synthetic glycopeptide epitopes
46. Model and simulation of multivalent binding to fixed ligands
47. Biological activity of human-mouse IgG1, IgG2, IgG3 and IgG4 chimeric monoclonal antibodies with antitumor specificity
48. Polymeric immunoglobulin M is secreted by transfectants of non- lymphoid cells in the absence of immunoglobulin J chain
49. IgM-Molecular requirements for its assembly and function